The validity of clinic-based samples in approximating out-of-care HIV-infected populations
Manya Magnus(Milken Institute), Michael Kaiser(NewYork–Presbyterian Brooklyn Methodist Hospital), Joe Foxhood, Amir Abrams(Louisiana State University), DeAnn Gruber(Louisiana State Department of Health and Hospitals), Jane Herwehe(Louisiana State University), Wayne Wilbright(Louisiana State University Health Sciences Center New Orleans), Luis Smith(Louisiana State University), Kathryn DeYoung(George Washington University), Ke Xiao(Louisiana State University), Elizabeth Shepard(Louisiana State Department of Health and Hospitals)
Cited by 5
Related Papers
Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United States
|AIDS and Behavior|2014|303
Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061
|PLoS ONE|2013|196
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|173
Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2007|169